Cancer as a manifestation of aberrant chromatin structure.
暂无分享,去创建一个
[1] Jo Handelsman,et al. EPIGENETIC REGULATION OF CELLULAR MEMORY BY THE POLYCOMB AND TRITHORAX GROUP PROTEINS , 2008 .
[2] Kelly M. McGarvey,et al. The cancer epigenome--components and functional correlates. , 2006, Genes & development.
[3] Anke Sparmann,et al. Polycomb silencers control cell fate, development and cancer , 2006, Nature Reviews Cancer.
[4] K. Ligon,et al. p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.
[5] R. DePinho,et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a , 2006, Nature.
[6] S. Morrison,et al. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing , 2006, Nature.
[7] M. Grever,et al. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. , 2006, Cancer research.
[8] Kelly M. McGarvey,et al. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. , 2006, Cancer research.
[9] Kelly M. McGarvey,et al. Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation , 2006, PLoS genetics.
[10] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[11] A. Feinberg,et al. The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.
[12] K. Robertson. DNA methylation and human disease , 2005, Nature Reviews Genetics.
[13] Rudolf Jaenisch,et al. Ectopic Expression of Oct-4 Blocks Progenitor-Cell Differentiation and Causes Dysplasia in Epithelial Tissues , 2005, Cell.
[14] D. Reinberg,et al. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Herman,et al. Promoter Hypermethylation of Resected Bronchial Margins , 2004, Clinical Cancer Research.
[16] A. Lund,et al. Polycomb complexes and silencing mechanisms. , 2004, Current opinion in cell biology.
[17] Peter A. Jones,et al. Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.
[18] Wei Dong Chen,et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.
[19] A. Feinberg,et al. The history of cancer epigenetics , 2004, Nature Reviews Cancer.
[20] Y. Schwartz,et al. Polycomb silencing mechanisms in Drosophila. , 2004, Cold Spring Harbor symposia on quantitative biology.
[21] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.
[22] Debashis Ghosh,et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Jaenisch,et al. Chromosomal Instability and Tumors Promoted by DNA Hypomethylation , 2003, Science.
[24] E. Selker,et al. Synthesis of Signals for De Novo DNA Methylation in Neurospora crassa , 2003, Molecular and Cellular Biology.
[25] C. Allis,et al. Histone and chromatin cross-talk. , 2003, Current opinion in cell biology.
[26] Manel Esteller,et al. Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. , 2003, Cancer research.
[27] Hengbin Wang,et al. Role of Histone H3 Lysine 27 Methylation in X Inactivation , 2003, Science.
[28] V. Orlando. Polycomb, Epigenomes, and Control of Cell Identity , 2003, Cell.
[29] P. Farnham,et al. Identification of the polycomb group protein SU(Z)12 as a potential molecular target for human cancer therapy. , 2003, Molecular cancer therapeutics.
[30] K. Chew,et al. Methylation of p 16 INK 4 a Promoters Occurs in Vivo in Histologically Normal Human Mammary Epithelia 1 , 2003 .
[31] M. Voso,et al. Background and Objectives. Methylation of DNA is a , 2022 .
[32] Peter A. Jones,et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment. , 2002, Blood.
[33] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.
[34] Xiaofeng Cao,et al. Interplay between Two Epigenetic Marks DNA Methylation and Histone H3 Lysine 9 Methylation , 2002, Current Biology.
[35] M. Ehrlich. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. , 2002, The Journal of nutrition.
[36] Brian D. Strahl,et al. Gene silencing: Trans-histone regulatory pathway in chromatin , 2002, Nature.
[37] Matty P. Weijenberg,et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer , 2002, Nature Genetics.
[38] J. P. Jackson,et al. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase , 2002, Nature.
[39] A. Wolffe,et al. Precipitous Release of Methyl-CpG Binding Protein 2 and Histone Deacetylase 1 from the Methylated Human Multidrug Resistance Gene (MDR1) on Activation , 2002, Molecular and Cellular Biology.
[40] Gangning Liang,et al. Cooperativity between DNA Methyltransferases in the Maintenance Methylation of Repetitive Elements , 2002, Molecular and Cellular Biology.
[41] A. Bird. DNA methylation patterns and epigenetic memory. , 2002, Genes & development.
[42] E. Selker,et al. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa , 2001, Nature.
[43] S. Baylin,et al. Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.
[44] C. Allis,et al. Translating the Histone Code , 2001, Science.
[45] S. Baylin,et al. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci , 2000, Nature Genetics.
[46] Peter L. Jones,et al. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters , 2000, Nature Genetics.
[47] Luke Hughes-Davies,et al. DNA methyltransferase Dnmt1 associates with histone deacetylase activity , 2000, Nature Genetics.
[48] A. Bird,et al. Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.
[49] R. Kornberg,et al. Twenty-Five Years of the Nucleosome, Fundamental Particle of the Eukaryote Chromosome , 1999, Cell.
[50] Peter A. Jones,et al. Cancer-epigenetics comes of age , 1999, Nature Genetics.
[51] J. Herman,et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.
[52] S. Schwartz,et al. The identification of monoclonality in human aberrant crypt foci. , 1999, Cancer research.
[53] E Gabrielson,et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. Wong,et al. Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation , 1998, Molecular and Cellular Biology.
[55] J. Nathans,et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Herman,et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.
[57] K. Kinzler,et al. Molecular determinants of dysplasia in colorectal lesions. , 1994, Cancer research.
[58] Rudolf Jaenisch,et al. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.
[59] E. Selker,et al. A portable signal causing faithful DNA methylation de novo in Neurospora crassa. , 1987, Science.
[60] A. Feinberg,et al. Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.